ArticleBMC cancer2022

Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma.

Genhao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.